62MO A randomised, controlled, multicenter phase II trial of camrelizumab combined with albumin-bound paclitaxel and cisplatin as neoadjuvant treatment in locally advanced NSCLC
Jie Lei, Xiaolong Yan, Jian Zhao, Feng Tian, Qun Lu, Tao Jiang
Topics & Concepts
MedicineClinical endpointInternal medicineInterim analysisResponse Evaluation Criteria in Solid TumorsChemotherapyNeoadjuvant therapyCisplatinOncologyPaclitaxelPhases of clinical researchSurgeryGastroenterologyRandomized controlled trialCancerBreast cancerCancer Immunotherapy and BiomarkersEsophageal Cancer Research and TreatmentLung Cancer Diagnosis and Treatment